Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ublituximab
ublituximab
ICER on MS drugs: TG's ublituximab not cost effective at the same price as Roche's ocrelizimab
Endpoints
Tue, 10/18/22 - 10:36 am
ICER
MS
multiple sclerosis
drug pricing
ublituximab
TG Therapeutics
Samsung Biologics and TG Therapeutics expand blood cancer partnership
Biopharma Reporter
Tue, 04/27/21 - 10:53 am
TG Therapeutics
Samsung BioLogics
ublituximab
monoclonal antibodies
TG adds a multiple sclerosis string to its bow
EP Vantage
Fri, 12/11/20 - 11:07 am
TG Therapeutics
hematology
ASH2020
ublituximab
MS
multiple sclerosis
3 Biotech Stocks With Major Catalysts Incoming
Motley Fool
Fri, 04/20/18 - 12:45 pm
Incyte
TG Therapeutics
Cara Therapeutics
CR845
opioids
ublituximab
leukemia
olumiant
rheumatoid arthritis
Data from trials could send these clinical-stage biotech stocks soaring or crashing
Motley Fool
Mon, 02/5/18 - 08:26 am
clinical trials
biotech
Summit Therapeutics
DMD
Jounce Therapeutics
JTX-2011
TG Therapeutics
ublituximab
The 'Gnarly 9' Biotechs Will Test the FDA's Mettle
TheStreet.com
Thu, 03/9/17 - 11:25 am
FDA
drug approvals
Alkermes
ALKS-5461
CytRx
aldoxorubicin
Dynavax Technologies
HEPLISAV-B
Intra-Cellular Therapies
ITI-007
Novan
SB204
Portola Pharmaceuticals
betrixaban
PTC Therapeutics
ataluren
Rigel Pharmaceuticals
fostamatinib
TG Therapeutics
ublituximab
TG Therapeutics shares rocket up on successful PhIII leukemia study, teeing up a shot at accelerated FDA OK
Endpoints
Mon, 03/6/17 - 09:47 am
TG Therapeutics
ublituximab
TG-1101
FDA
CLL